Pfizer will deliver faster-than-expected doses of Covid vaccine from the United States

Sign up here for our daily coronavirus newsletter on what you need to know and subscribe to our Covid-19 podcast for the latest news and reviews.

Pfizer Inc. will be able to supply the US 200 million doses of Covid-19 vaccine by the end of May, two months earlier than previously expected, according to its leadership.

Executive Director Albert Bourla said on Tuesday that the drug manufacturer and its partner, BioNTech SE, will be able to deliver the doses to the US well before the July 31 deadline, due to a change in the vaccine label that allows health care providers to extract a extra dose from each vial.

The six-dose vial took effect Monday and applies to future supply contracts, according to a Pfizer representative.

In the U.S., Pfizer and BioNTech will deliver 120 million doses in the first quarter, 20 million more than originally promised, Bourla said in an interview with Bloomberg chief editor John Micklethwait at the Year Ahead Summit. which took place practically this year.

Bourla added that Pfizer and BioNTech will receive more doses to the European Union before the end of the second quarter. The vaccination regimen of the companies requires two doses to ensure complete protection against symptomatic cases of Covid-19.

.Source